Bio Green Med Solution, Inc. (BGMS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bio Green Med Solution, Inc. on March 12, 2026. The Company is incorporated in Delaware and maintains its principal executive offices in Kuala Lumpur, Malaysia. The report addresses a specific regulatory event concerning the Company's 6% Convertible Exchangeable Preferred Stock (Symbol: BGMSP) listed on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on listing compliance status rather than financial performance metrics.
Material Changes and Events
- Delisting Notification: On March 12, 2026, Nasdaq notified the Company that its Preferred Stock (BGMSP) failed to regain compliance with Listing Rule 5555(a)(4) regarding the Minimum Market Value of Publicly Held Shares (MVPHS) of $1 million.
- Compliance History: The Company had previously received notice on September 11, 2025, of non-compliance and was granted an 180-day period to regain compliance, which expired on March 10, 2026.
- Delisting Timeline: As the Company does not intend to appeal the determination, trading of the Preferred Stock is expected to be suspended on March 23, 2026. Formal delisting from The Nasdaq Capital Market is expected to occur on or after April 2, 2026.
- Future Trading Venue: The Company anticipates that the Preferred Stock may be quoted and traded on the OTC Markets following delisting.
- Common Stock Status: The delisting action applies only to the Preferred Stock (BGMSP) and does not affect the listing of the Company's Common Stock (BGMS) on The Nasdaq Capital Market.
Outlook, Risks, and Management Commentary
Management has explicitly stated it does not intend to request an appeal of the Nasdaq determination. The filing includes standard forward-looking statements cautioning that actual results may differ due to risks and uncertainties. The primary risk identified is the loss of the Nasdaq listing for the Preferred Stock, which may impact liquidity and market visibility for that specific security class.
Investor Verification Checklist
- Verify the exact date of trading suspension for BGMSP (expected March 23, 2026).
- Confirm the ticker symbol and trading venue for BGMSP on the OTC Markets post-delisting.
- Review the Company's most recent 10-K or 10-Q filings for the underlying financial reasons contributing to the low Market Value of Publicly Held Shares.
- Confirm that the Common Stock (BGMS) remains in good standing on The Nasdaq Capital Market.